Patent ID: 11932702
Assignee: ABLYNX N.V.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 3:
4. The polypeptide according to claim 1, wherein:
a) said first ISVD comprises a CDR1 consisting of the amino acid sequence of SEQ ID NO: 6, a CDR2 consisting of the amino acid sequence of SEQ ID NO: 10 and a CDR3 consisting of the amino acid sequence of SEQ ID NO: 14;
b) said second ISVD comprises a CDR1 consisting of the amino acid sequence of SEQ ID NO: 7, a CDR2 consisting of the amino acid sequence of SEQ ID NO: 11 and a CDR3 consisting of the amino acid sequence of SEQ ID NO: 15; and
c) said third ISVD comprises a CDR1 consisting of the amino acid sequence of SEQ ID NO: 8, a CDR2 consisting of the amino acid sequence of SEQ ID NO: 12 and a CDR3 consisting of the amino acid sequence of SEQ ID NO: 16.